TFCM
CLPT icon

Taylor Frigon Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Taylor Frigon Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
132,009
+108
+0.1% +$1.35K 1.1% 35
2026
Q1 		$1.2M Sell
131,901
-517
-0.4% -$6.53K 0.68% 86
2025
Q4 		$1.81M Sell
132,418
-1,606
-1% -$29.8K 0.92% 56
2025
Q3 		$2.92M Sell
134,024
-46,425
-26% -$547K 1.45% 15
2025
Q2 		$2.15M Sell
180,449
-11,211
-6% -$141K 1.15% 41
2025
Q1 		$2.28M Sell
191,660
-20,586
-10% -$320K 1.36% 16
2024
Q4 		$3.26M Sell
212,246
-162,551
-43% -$2.11M 1.65% 17
2024
Q3 		$4.2M Sell
374,797
-49,738
-12% -$476K 2.09% 5
2024
Q2 		$2.29M Buy
424,535
+438
+0.1% +$2.54K 1.09% 35
2024
Q1 		$2.88M Buy
424,097
+71,491
+20% +$500K 1.37% 30
2023
Q4 		$2.39M Sell
352,606
-1,262
-0.4% -$7.14K 1.2% 32
2023
Q3 		$1.77M Buy
353,868
+107,441
+44% +$639K 0.99% 41
2023
Q2 		$1.78M Buy
246,427
+78,438
+47% +$667K 0.87% 46
2023
Q1 		$1.42M Sell
167,989
-3,725
-2% -$32.6K 0.77% 57
2022
Q4 		$1.45M Sell
171,714
-7,066
-4% -$67K 0.83% 47
2022
Q3 		$1.85M Buy
178,780
+4,054
+2% +$53.4K 0.97% 42
2022
Q2 		$2.28M Sell
174,726
-6,603
-4% -$67.5K 1.19% 33
2022
Q1 		$1.89M Buy
181,329
+6,176
+4% +$56.2K 0.7% 51
2021
Q4 		$1.97M Sell
175,153
-1,111
-0.6% -$16.6K 0.62% 51
2021
Q3 		$3.13M Buy
176,264
+574
+0.3% +$10.8K 1.01% 44
2021
Q2 		$3.35M Buy
175,690
+119,773
+214% +$2.31M 1.05% 44
2021
Q1 		$1.18M Buy
+55,917
New +$1.2M 0.36% 69

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Taylor Frigon Capital Management's CLPT Position: Q2 2026 in Review

Taylor Frigon Capital Management increased its ClearPoint Neuro (CLPT) stake by 0.08% in Q2 2026, buying an estimated $1.35K and bringing the position to 132,009 shares worth $2.36M. The position accounts for 1.1% of the portfolio, ranked #35.

Taylor Frigon Capital Management first reported a position in CLPT in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.2M in Q3 2024. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Taylor Frigon Capital Management held 132,009 shares of ClearPoint Neuro worth $2.36M as of Q2 2026.
  • Taylor Frigon Capital Management bought 108 ClearPoint Neuro shares in Q2 2026, an estimated $1.35K.
  • ClearPoint Neuro made up 1.1% of Taylor Frigon Capital Management's portfolio in Q2 2026, its #35 holding.
  • Taylor Frigon Capital Management first reported a position in ClearPoint Neuro in Q1 2021 and has held it in 22 quarters since.
  • Taylor Frigon Capital Management's ClearPoint Neuro position peaked at $4.2M in Q3 2024.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Taylor Frigon Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.